These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 15850772
1. Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway. Yu C, Mao X, Li WX. Biochem Biophys Res Commun; 2005 Jun 03; 331(2):391-7. PubMed ID: 15850772 [Abstract] [Full Text] [Related]
2. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C, Rahmani M, Dai Y, Conrad D, Krystal G, Dent P, Grant S. Cancer Res; 2003 Apr 15; 63(8):1822-33. PubMed ID: 12702569 [Abstract] [Full Text] [Related]
4. Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways. Hahn M, Li W, Yu C, Rahmani M, Dent P, Grant S. Mol Cancer Ther; 2005 Mar 15; 4(3):457-70. PubMed ID: 15767555 [Abstract] [Full Text] [Related]
5. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. Rahmani M, Reese E, Dai Y, Bauer C, Payne SG, Dent P, Spiegel S, Grant S. Cancer Res; 2005 Mar 15; 65(6):2422-32. PubMed ID: 15781658 [Abstract] [Full Text] [Related]
7. Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition. Rahmani M, Yu C, Reese E, Ahmed W, Hirsch K, Dent P, Grant S. Oncogene; 2003 Sep 18; 22(40):6231-42. PubMed ID: 13679862 [Abstract] [Full Text] [Related]
8. 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process. Gao N, Rahmani M, Dent P, Grant S. Oncogene; 2005 May 26; 24(23):3797-809. PubMed ID: 15782127 [Abstract] [Full Text] [Related]
9. Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Woo KJ, Jeong YJ, Park JW, Kwon TK. Biochem Biophys Res Commun; 2004 Dec 24; 325(4):1215-22. PubMed ID: 15555556 [Abstract] [Full Text] [Related]
10. The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells. Maggio SC, Rosato RR, Kramer LB, Dai Y, Rahmani M, Paik DS, Czarnik AC, Payne SG, Spiegel S, Grant S. Cancer Res; 2004 Apr 01; 64(7):2590-600. PubMed ID: 15059916 [Abstract] [Full Text] [Related]
11. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. Pfeil K, Eder IE, Putz T, Ramoner R, Culig Z, Ueberall F, Bartsch G, Klocker H. Prostate; 2004 Feb 15; 58(3):259-68. PubMed ID: 14743465 [Abstract] [Full Text] [Related]
12. Beta-sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells. Moon DO, Lee KJ, Choi YH, Kim GY. Int Immunopharmacol; 2007 Aug 15; 7(8):1044-53. PubMed ID: 17570321 [Abstract] [Full Text] [Related]
13. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. Tsurutani J, West KA, Sayyah J, Gills JJ, Dennis PA. Cancer Res; 2005 Sep 15; 65(18):8423-32. PubMed ID: 16166321 [Abstract] [Full Text] [Related]
14. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Wlodarski P, Kasprzycka M, Liu X, Marzec M, Robertson ES, Slupianek A, Wasik MA. Cancer Res; 2005 Sep 01; 65(17):7800-8. PubMed ID: 16140948 [Abstract] [Full Text] [Related]
15. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition. MacKeigan JP, Taxman DJ, Hunter D, Earp HS, Graves LM, Ting JP. Clin Cancer Res; 2002 Jul 01; 8(7):2091-9. PubMed ID: 12114408 [Abstract] [Full Text] [Related]
16. LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway. Poh TW, Pervaiz S. Cancer Res; 2005 Jul 15; 65(14):6264-74. PubMed ID: 16024628 [Abstract] [Full Text] [Related]
17. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Uddin S, Hussain AR, Al-Hussein KA, Manogaran PS, Wickrema A, Gutierrez MI, Bhatia KG. Clin Cancer Res; 2005 Apr 15; 11(8):3102-8. PubMed ID: 15837766 [Abstract] [Full Text] [Related]
18. Reversal of boswellic acid analog BA145 induced caspase dependent apoptosis by PI3K inhibitor LY294002 and MEK inhibitor PD98059. Pathania AS, Joshi A, Kumar S, Guru SK, Bhushan S, Sharma PR, Bhat WW, Saxena AK, Singh J, Shah BA, Andotra SS, Taneja SC, Malik FA, Kumar A. Apoptosis; 2013 Dec 15; 18(12):1561-73. PubMed ID: 23948751 [Abstract] [Full Text] [Related]
19. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. Tabellini G, Cappellini A, Tazzari PL, Falà F, Billi AM, Manzoli L, Cocco L, Martelli AM. J Cell Physiol; 2005 Feb 15; 202(2):623-34. PubMed ID: 15316930 [Abstract] [Full Text] [Related]
20. Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity. Zhang L, Himi T, Morita I, Murota S. Cell Death Differ; 2001 May 15; 8(5):528-36. PubMed ID: 11423913 [Abstract] [Full Text] [Related] Page: [Next] [New Search]